CCN1 and osteosarcoma: As expected, we found that VP inhibited YAP/TAZ transcriptional activity as well as their expression (Figure 2D,E), as evidenced by its marker genes’ expression (CYR61 and CTGF) (Figure 2F), indicating that inhibition of Hippo pathway by VP may be a potential strategy for treatment of osteosarcoma.